Undervalued Stocks Based On Cash Flows
Resultaten
7
1 nieuw
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
7 bedrijven
| Bedrijf | Laatste prijs | 7D Terugkeer | 1 J Rendement | Marktkapitalisatie | Doel analisten | Waardering | Groei | Div Opbrengst | Industrie | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
PRS | €2.83 | 0.4% | -22.3% | €382.3m | €4.22 | 0.4 | 75.1% | n/a | Media | ||
ALM Nieuw | €10.40 | 0% | -8.8% | €2.3b | €14.30 | 38.3 | 25.6% | 1.8% | Pharmaceuticals & Biotech | ||
ROVI | €61.50 | 2.7% | 5.4% | €3.1b | €74.36 | 17.0 | 12.2% | 1.6% | Pharmaceuticals & Biotech | ||
PANG | €1.55 | 0% | -9.9% | €55.7m | n/a | 3.3 | 96.1% | n/a | Pharmaceuticals & Biotech | ||
TUB | €2.93 | 0% | -21.2% | €358.2m | €4.14 | 0.5 | 82.9% | 6.9% | Materials | ||
ART | €29.20 | -0.7% | 124.6% | €1.7b | €34.25 | 30.0 | 22.8% | 0.6% | Capital Goods | ||
ACX | €17.84 | 4.9% | 67.5% | €4.4b | €18.30 | 82.2 | 33.5% | 3.5% | Materials |
Page 1 of 1